Curevac N V (CVAC) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Curevac N v   (NASDAQ: CVAC)


Curevac N V's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Curevac N V's ROI in the second quarter of 2025?
Curevac N v achieved a return on average invested assets (ROI) of 26.79 % in its second quarter of 2025, this is above CVAC's average return on investment of -13.72%.
Curevac N V invested over the 12 months ending in its second quarter of 2025 $776 million

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2025.

Within the Healthcare sector 52 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2025 from 293 to 376.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter
Y / Y Investment Change TTM 3.95 % 11.99 % 21.02 % 12.4 % 5.4 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 731 735 818 818 818
Return On Investment (TTM) 26.79 % 24.73 % 21.45 % 15.76 % -40.35 %
CVAC's Overall Ranking # 376 # 293 # # #
Seq. Investment Change TTM -2.74 % -2.53 % 4.6 % 4.83 % 4.79 %
Seq. Net Income Change TTM 5.35 % 12.39 % 42.32 % - -
Net Income (TTM) in Millions 208 197 175 123 -301

CVAC Company Profile >> Back to CVAC Roi Comparisons >> See Annual CVAC Return On Investment



Return On Investment CVAC's Ranking
Within: No.
Industry # 24
Sector # 53
Overall # 376

Return On Investment Statistics
High Average Low
19.86 %
-13.72 %
-32.91 %
(Dec 31 2024)   (Dec 31 2023)







Financial Statements
Curevac N V's II. Quarter Investments $ 731 Millions CVAC's Balance sheet
Curevac N V's II. Quarter Income $ -68 Millions Quarterly CVAC's Income Statement
CVAC's Income by Division See CVAC's Income by Division


CVAC Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2020)
2020
Total Investments in Millions 818 674 753 1,415 0
Y / Y Investment Growth 21.37 % -10.53 % -46.77 % - -
Net Income in Millions 182 -291 -262 -145 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 22.2 % -43.23 % -34.82 % -10.22 % -


Annual Roi Comment
In the fiscal year 2024 ROI improved to 22.2 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CVAC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CVAC's Competitors
Subscribers only: Roi for Curevac N V's Suppliers
Subscribers only: Return On Investment for CVAC's Customers

Other Ratios
CVAC's Roa CVAC's Inventory Turnover Ratio CVAC's Growth Rates CVAC's Dividend Statistics
CVAC's Profitability Ratios CVAC's Asset Turnover Ratio CVAC's Dividend Growth
CVAC's Roe CVAC's Valuation Ratios CVAC's Financial Strength Ratios CVAC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI
Stablecoin Development Corporation  66.04 %
Novavax inc   56.96 %
Exelixis Inc   55.73 %
Biomx Inc  53.39 %
Adma Biologics Inc   49.11 %
Medinotec Inc   48.14 %
Abeona Therapeutics Inc   46.96 %
Synlogic Inc   46.41 %
Dariohealth Corp   45.05 %
Idexx Laboratories Inc  44.34 %
Entera Bio Ltd   43.13 %
Puma Biotechnology Inc   42.38 %
Agios Pharmaceuticals Inc   41.91 %
Siga Technologies Inc  38.92 %
Ptc Therapeutics inc   38.85 %
Mettler toledo International Inc   36.69 %
Edwards Lifesciences Corporation  35.59 %
Minerva Neurosciences Inc   34.19 %
Arcutis Biotherapeutics Inc   34.15 %
Longduoduo Co Ltd  33.92 %
Illumina Inc   32.26 %
Medpace Holdings Inc   32.18 %
Sbc Medical Group Holdings Incorporated  30.79 %
Nutriband Inc   30.56 %
Halozyme Therapeutics Inc   28.22 %
Acadia Pharmaceuticals Inc   28.20 %
Catalyst Pharmaceuticals Inc   27.33 %
Eli Lilly And Company  25.82 %
Rafael Holdings Inc  25.67 %
Hims and Hers Health Inc   24.46 %

Date modified: 2026-09-18T16:09:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.